Evidence map›Paper›PMID 41098430›Full record

ReviewOncology letters2025

Roles of β-catenin protein in non-small cell lung cancer (Review).

Lina Peng, Ran Gao, Liping Han, Tian Fu, Cuixia Bian

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lina PengDepartment of Respiratory and Critical Care Medicine, Jining First People's Hospital, Jining, Shandong 272000, P.R. China.
Ran GaoDepartment of Respiratory Medicine, Jiaxiang People's Hospital, Jining, Shandong 272400, P.R. China.
Liping HanDepartment of Respiratory and Critical Care Medicine, Jining First People's Hospital, Jining, Shandong 272000, P.R. China.
Tian FuDepartment of Respiratory and Critical Care Medicine, Jining First People's Hospital, Jining, Shandong 272000, P.R. China.
Cuixia BianDepartment of Respiratory and Critical Care Medicine, Jining First People's Hospital, Jining, Shandong 272000, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer remains the leading cause of cancer-related death globally, with non-small cell lung cancer (NSCLC) accounting for the majority of lung cancer cases. Therefore, understanding the mechanisms underlying NSCLC development is essential. Cancer cells can influence the tumor immune microenvironment, angiogenesis, apoptosis and epithelial-mesenchymal transition (EMT) through various cell signaling pathways. Among these, the β-catenin protein, encoded by the

Indexed as

CTNNB1EGFR-TKIsEMTICIsNSCLCTMEWnt signaling pathway

Identifiers

PMID41098430
PMCPMC12519066

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.